These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 26961461

  • 1. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.
    Granata A, Clementi A, Virzì GM, Brocca A, de Cal M, Scarfia VR, Zanoli L, Ronco C, Corrao S, Malatino L.
    Eur J Intern Med; 2016 May; 30():1-6. PubMed ID: 26961461
    [Abstract] [Full Text] [Related]

  • 2. Cardiorenal syndrome type 4: management.
    Clementi A, Virzì GM, Brocca A, de Cal M, Vescovo G, Granata A, Ronco C.
    Blood Purif; 2013 May; 36(3-4):200-9. PubMed ID: 24496191
    [Abstract] [Full Text] [Related]

  • 3. Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease.
    H S, B S A, Moger V, Swamy M.
    Indian Heart J; 2017 May; 69(1):11-16. PubMed ID: 28228293
    [Abstract] [Full Text] [Related]

  • 4. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Tumlin JA, Costanzo MR, Chawla LS, Herzog CA, Kellum JA, McCullough PA, Ronco C.
    Contrib Nephrol; 2013 May; 182():158-73. PubMed ID: 23689661
    [Abstract] [Full Text] [Related]

  • 5. Cardiac Hypertrophy and Cardiac Cell Death in Chronic Kidney Disease.
    Rofe MT, Levi R, Hertzberg-Bigelman E, Goryainov P, Barashi R, Ben-Shoshan J, Keren G, Entin-Meer M.
    Isr Med Assoc J; 2015 Dec; 17(12):744-9. PubMed ID: 26897975
    [Abstract] [Full Text] [Related]

  • 6. Cardiorenal syndrome in chronic kidney disease.
    Tsuruya K, Eriguchi M.
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):154-62. PubMed ID: 25636143
    [Abstract] [Full Text] [Related]

  • 7. Chronic kidney disease and cardiovascular complications.
    Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C.
    Heart Fail Rev; 2015 May; 20(3):259-72. PubMed ID: 25344016
    [Abstract] [Full Text] [Related]

  • 8. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG, Uecer E, Stadler S, Birner C, Buchner S, Maier LS, Luchner A.
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [Abstract] [Full Text] [Related]

  • 9. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
    Halimi JM, de Fréminville JB, Gatault P, Bisson A, Gueguen J, Goin N, Sautenet B, Maisons V, Herbert J, Angoulvant D, Fauchier L.
    Nephrol Dial Transplant; 2022 Nov 23; 37(12):2386-2397. PubMed ID: 35438794
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heart Disease and the Kidneys.
    Silva RP, Diógenes C.
    Contrib Nephrol; 2021 Nov 23; 199():71-79. PubMed ID: 34428764
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular Disease Risk in Children With Kidney Disease.
    Sethna CB, Merchant K, Reyes A.
    Semin Nephrol; 2018 May 23; 38(3):298-313. PubMed ID: 29753405
    [Abstract] [Full Text] [Related]

  • 13. The cardiorenal syndrome: what the cardiologist needs to know.
    Waldum B, Os I.
    Cardiology; 2013 May 23; 126(3):175-86. PubMed ID: 24022166
    [Abstract] [Full Text] [Related]

  • 14. Cardiorenal syndrome.
    Ronco C, Di Lullo L.
    Heart Fail Clin; 2014 Apr 23; 10(2):251-80. PubMed ID: 24656104
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.
    Tomey MI, Winston JA.
    Ann Glob Health; 2014 Apr 23; 80(1):69-76. PubMed ID: 24751567
    [Abstract] [Full Text] [Related]

  • 17. The burden of cardiovascular risk in chronic kidney disease and dialysis patients (cardiorenal syndrome type 4).
    House AA, Ronco C.
    Contrib Nephrol; 2011 Apr 23; 171():50-56. PubMed ID: 21625089
    [Abstract] [Full Text] [Related]

  • 18. Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters.
    Lai S, Ciccariello M, Dimko M, Galani A, Lucci S, Cianci R, Mariotti A.
    Kidney Blood Press Res; 2016 Apr 23; 41(5):654-662. PubMed ID: 27665506
    [Abstract] [Full Text] [Related]

  • 19. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 20. [Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease].
    Severova MM, Saginova EA, Galliamov MG, Ermakov NV, Rodina AV, Fomin VV, Mukhin NA.
    Ter Arkh; 2012 Feb 05; 84(6):15-20. PubMed ID: 22997912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.